ED drug market foreign capital one-third of the pattern will change
- Release date:
The industry refers to the foreign ED products is Pfizer Viagra, Eli Lilly and Bayer Elite. Since 1998, Viagra has been the first to enter China, it monopolize the market for 6 years. Until 2004 and 2005, Bayer and Eli Lilly has entered China, the three parties melee started.
Despite the large number of competitors, according to IMS (a professional medical database) data shows that Viagra in 2013 is still 58.8% of the market which share topped the list, Eli Lilly ranked second. The industry said that in order to consolidate the leading position of Viagra, Pfizer has begun to set the market before the patent protection expires. In 2011, the company will integrate some of the retail stores of male prescription drugs and family planning equipment business, and in 2013 to the second and third tier cities to complete at least 200 products recommended. The official figures Pfizer published in 2013 showed that Viagrai can sell more than 1 billion yuan in China, the sales channel power is evident.
But now the "Jin Ge" appeared in the market, and in the future there are Le Pu medical, Long St. medicine, Neptune biological), Qilu Pharmaceutical, Luo Xin Pharmaceutical, the Central Pharmaceutical, Changshan Pharmaceutical more than 10 generic enterprises , Once declared successful approval, "Viagra" how to maintain market share? The market is generally considered generic drugs listed, at least to seize 30% market.
Wellman Pharmaceutical Chairman Sun Mingjie had expected that China's ED treatment of drugs at least have 60 billion yuan of market in potential.